NapaJen Pharma
Latest round
- Series B
Last raised
- Nov 2016
Total raised
- $27M
Investors
- 4
About NapaJen Pharma
Founded in 2005 and based in California, US, NapaJen Pharma, Inc. is a pharmaceutical company that engages in the research and development of drugs for hematopoietic stem cell transplantation in hematological cancers. The firm was founded as Napa Jenomics Corporation, and initially focused on nucleic acid drug discovery. In March 2024, INCJ, Inc. exited all its stake in NapaJen Pharma, Inc., Ltd. NapaJen Pharma's technology platform addresses the significant challenges of delivering oligonucleotide drugs to target immune cells. By binding directly to the Dectin-1 receptor on antigen-presenting cells, their approach enhances the stability, bioavailability, and cellular uptake of these drugs. This technology accelerates the development process, from target identification to lead optimization. Additionally, the company operates a dual-pronged development strategy, managing both internal drug programs and collaborative projects with biotechnology and pharmaceutical companies. Key offerings include their flagship therapeutic, NJA-730, which is in Phase 1 clinical trials and aims to treat acute graft-versus-host disease (GvHD).
Who invested in NapaJen Pharma
4 investors across 2 rounds
See all investors in NapaJen Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NapaJen Pharma
Who invested in NapaJen Pharma?
NapaJen Pharma has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NapaJen Pharma raised?
NapaJen Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did NapaJen Pharma last raise money?
NapaJen Pharma's most recent round on record is a Series B, in Nov 2016.
What does NapaJen Pharma do?
Founded in 2005 and based in California, US, NapaJen Pharma, Inc.
Where is NapaJen Pharma headquartered?
NapaJen Pharma is headquartered in Seattle, US.
Which VCs invest in companies like NapaJen Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at NapaJen Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like NapaJen Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.